Squarepoint
BKYI

Squarepoint’s BIO-key International BKYI Stock Holding History

Squarepoint’s Portfolio BKYI Stock Details BKYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-123
Closed -$77K – 3235
2021
Q1 		$77K Buy
123
+52
+73% +$37.5K ﹤0.01% 2952
2020
Q4 		$45K Buy
71
+45
+173% +$28.5K ﹤0.01% 2808
2020
Q3 		$16K Buy
+26
New +$24.6K ﹤0.01% 2424

Other funds holding BKYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $36.1B AUM 19.68% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Squarepoint's BKYI Position: Q2 2021 in Review

Squarepoint sold out of BIO-key International (BKYI) in Q2 2021, closing a stake of 123 shares — an estimated $77K sold.

Squarepoint first reported a position in BKYI in Q3 2020 and held it in 3 quarters. The position peaked at $77K in Q1 2021. 13 funds tracked by Wall St. Rank hold BKYI as of Q2 2021.

  • Squarepoint reported no remaining BIO-key International position as of Q2 2021 after selling out during the quarter.
  • Squarepoint sold 123 BIO-key International shares in Q2 2021, an estimated $77K.
  • Squarepoint first reported a position in BIO-key International in Q3 2020 and held it in 3 quarters.
  • Squarepoint's BIO-key International position peaked at $77K in Q1 2021.
  • 13 funds tracked by Wall St. Rank held BIO-key International as of Q2 2021.

Based on Squarepoint's 13F filing for Q2 2021, filed 16 Aug 2021.